New CEO at Prohealth
Peter Apap, co-founder and director of Prohealth Ltd, has been appointed chief executive officer.
Prohealth has imported and distributed leading pharmaceutical and dermo-cosmetic brands since 1995.
The other co-founders and executive directors John Jaccarini and Andrew Paris have responsibility for export business development, and procurement and regulatory affairs respectively. Joseph FX Zahra, who has been a consultant with Prohealth for the last two years, chairs the board of directors in a non-executive capacity.
The company also announced the appointment of Andrew Spiteri Willets as financial controller.
These changes are aimed at growing the company’s market share in Malta, by consolidation of its brands such as La Roche-Posay, Vichy, Ursapharm and Kin, as well as the introduction of new products, and continued rapid growth of its more recently established medical devices division.
This restructuring will enable Prohealth to embark on a more aggressive drive to develop business in new export markets in addition to its established Libya market.